Clinical trial
A Phase I Clinical Study Evaluating the Safety, Pharmacokinetics, Food Effect, Single-Dose Proportionality, and Multiple-Dose Pharmacokinetic Comparison With Melogabalin Besilate Tablets After Single and Multiple Oral Administrations of BM2216 Extended-Release Tablets in Healthy Adult Subjects.--Single-Center, Randomized, Open-Label, Parallel/Crossover Design.
NCT06846567 is registered in ClinicalTrials.gov with Zhejiang Anglikang Pharmaceutical Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase I Clinical Study Evaluating the Safety, Pharmacokinetics, Food Effect, Single-Dose Proportionality, and Multiple-Dose Pharmacokinetic Comparison With Melogabalin Besilate Tablets After Single and Multiple Oral Administrations of BM2216 Extended-Release Tablets in Healthy Adult Subjects.--Single-Center, Randomized, Open-Label, Parallel/Crossover Design.
- Lead sponsor
- Zhejiang Anglikang Pharmaceutical Co., Ltd.
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- December 1, 2024
- Completion date
- January 12, 2025
- Enrollment
- 66 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.